Published in J Virol on May 01, 2002
A human lung carcinoma cell line supports efficient measles virus growth and syncytium formation via a SLAM- and CD46-independent mechanism. J Virol (2007) 1.39
Multiple amino acid substitutions in hemagglutinin are necessary for wild-type measles virus to acquire the ability to use receptor CD46 efficiently. J Virol (2006) 1.19
Measles virus, immune control, and persistence. FEMS Microbiol Rev (2012) 1.12
Contributions of matrix and large protein genes of the measles virus edmonston strain to growth in cultured cells as revealed by recombinant viruses. J Virol (2005) 1.12
Ligand-directed gene targeting to mammalian cells by pseudotype baculoviruses. J Virol (2005) 0.91
Inhibition of interferon regulatory factor 3 activation by paramyxovirus V protein. J Virol (2012) 0.89
Wild-type measles virus with the hemagglutinin protein of the edmonston vaccine strain retains wild-type tropism in macaques. J Virol (2012) 0.88
Cell tropism and pathogenesis of measles virus in monkeys. Front Microbiol (2012) 0.86
Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene (1991) 38.64
Rescue of measles viruses from cloned DNA. EMBO J (1995) 7.87
The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell (1993) 7.71
Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol (1993) 7.27
SLAM (CDw150) is a cellular receptor for measles virus. Nature (2000) 6.07
Paramyxovirus fusion: a hypothesis for changes. Virology (1993) 4.98
Studies on an attenuated measles-virus vaccine. I. Development and preparations of the vaccine: technics for assay of effects of vaccination. N Engl J Med (1960) 4.12
Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J Virol (1990) 3.60
Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. J Virol (1998) 3.27
Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J Virol (2001) 3.27
A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J (1998) 2.48
Recovery of pathogenic measles virus from cloned cDNA. J Virol (2000) 2.19
Sequence divergence of measles virus haemagglutinin during natural evolution and adaptation to cell culture. J Gen Virol (1997) 2.00
CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition. J Virol (2001) 1.94
Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains. Proc Natl Acad Sci U S A (1995) 1.89
Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains. Virus Res (1994) 1.89
A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells. J Virol (1998) 1.88
The hemagglutinin of canine distemper virus determines tropism and cytopathogenicity. J Virol (2001) 1.88
CDw150(SLAM) is a receptor for a lymphotropic strain of measles virus and may account for the immunosuppressive properties of this virus. Virology (2001) 1.78
Clinical isolates of measles virus use CD46 as a cellular receptor. J Virol (2000) 1.72
Nonhuman primate models of measles. Lab Anim Sci (1996) 1.65
Viral replication and development of specific immunity in macaques after infection with different measles virus strains. J Infect Dis (1994) 1.65
Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46). Proc Natl Acad Sci U S A (1995) 1.64
Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains. J Infect Dis (1999) 1.62
Increased binding activity of measles virus to monkey red blood cells after long-term passage in Vero cell cultures. J Gen Virol (1994) 1.61
Temporal and geographical distribution of measles virus genotypes. J Gen Virol (1995) 1.61
A monoclonal antibody recognizes a human cell surface glycoprotein involved in measles virus binding. J Gen Virol (1992) 1.58
Measles virus attenuation associated with transcriptional impediment and a few amino acid changes in the polymerase and accessory proteins. J Virol (1998) 1.50
Moesin: a cell membrane protein linked with susceptibility to measles virus infection. Virology (1994) 1.44
Transcription inhibition and other properties of matrix proteins expressed by M genes cloned from measles viruses and diseased human brain tissue. J Virol (1994) 1.42
The H gene of rodent brain-adapted measles virus confers neurovirulence to the Edmonston vaccine strain. J Virol (1999) 1.38
Measles virus matrix protein specifies apical virus release and glycoprotein sorting in epithelial cells. EMBO J (2000) 1.33
Characterization of major structural proteins of measles virus with monoclonal antibodies. J Gen Virol (1985) 1.33
Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates. J Virol (2000) 1.31
A recombinant measles vaccine virus expressing wild-type glycoproteins: consequences for viral spread and cell tropism. J Virol (1999) 1.25
The hemagglutinin of recent measles virus isolates induces cell fusion in a marmoset cell line, but not in other CD46-positive human and monkey cell lines, when expressed together with the F protein. Arch Virol (1998) 1.20
Comparative nucleotide sequence analyses of the entire genomes of B95a cell-isolated and vero cell-isolated measles viruses from the same patient. Virus Genes (2000) 1.19
Is CD46 the cellular receptor for measles virus? Virus Res (1997) 1.17
Giant cell formation in lymphoid tissues of monkeys inoculated with various strains of measles virus. Jpn J Med Sci Biol (1970) 1.11
The haemagglutinin protein is an important determinant of measles virus tropism for dendritic cells in vitro. J Gen Virol (2001) 1.06
Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza. Vaccine (1998) 1.01
Variation in field isolates of measles virus during an 8-year period in Japan. Microbiol Immunol (1993) 0.97
Characterization of measles viruses isolated after measles vaccination. Vaccine (1995) 0.91
Blocking measles virus infection with a recombinant soluble form of, or monoclonal antibodies against, membrane cofactor protein of complement (CD46). Immunology (1995) 0.89
Isolation and characterization of the measles virus strains with low hemagglutination activity. Intervirology (1992) 0.86
Immunocytochemical focus assay for potency determination of measles-mumps-rubella trivalent vaccine. J Virol Methods (1987) 0.83
Antibody cross-reactivity with CD46 and lack of cell surface expression suggest that moesin might not mediate measles virus binding. J Virol (1997) 0.81
Moesin is not a receptor for measles virus entry into mouse embryonic stem cells. J Virol (1998) 0.81
The global circulation of seasonal influenza A (H3N2) viruses. Science (2008) 10.05
Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother (2006) 4.02
Characterization of H7N9 influenza A viruses isolated from humans. Nature (2013) 3.71
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine (2008) 2.56
Crystal structure of measles virus hemagglutinin provides insight into effective vaccines. Proc Natl Acad Sci U S A (2007) 2.56
Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis (2002) 2.38
Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat Med (2004) 2.31
Mitofusin 2 inhibits mitochondrial antiviral signaling. Sci Signal (2009) 2.25
Pause on avian flu transmission research. Science (2012) 2.24
SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J Virol (2002) 2.09
Proteolytic activation of the 1918 influenza virus hemagglutinin. J Virol (2009) 2.05
Measles virus: cellular receptors, tropism and pathogenesis. J Gen Virol (2006) 2.04
Global distribution of measles genotypes and measles molecular epidemiology. J Infect Dis (2011) 2.03
Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection. Proc Natl Acad Sci U S A (2005) 1.85
Influenza B virus BM2 protein has ion channel activity that conducts protons across membranes. Dev Cell (2003) 1.77
Measles virus V protein blocks interferon (IFN)-alpha/beta but not IFN-gamma signaling by inhibiting STAT1 and STAT2 phosphorylation. FEBS Lett (2003) 1.74
Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. Lancet Infect Dis (2011) 1.66
Measles virus infects both polarized epithelial and immune cells by using distinctive receptor-binding sites on its hemagglutinin. J Virol (2008) 1.62
Development of H5-RT-LAMP (loop-mediated isothermal amplification) system for rapid diagnosis of H5 avian influenza virus infection. Vaccine (2006) 1.61
Dissection of measles virus V protein in relation to its ability to block alpha/beta interferon signal transduction. J Gen Virol (2004) 1.59
Influenza virus hemagglutinin (H3 subtype) requires palmitoylation of its cytoplasmic tail for assembly: M1 proteins of two subtypes differ in their ability to support assembly. J Virol (2005) 1.58
Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine. J Infect Dis (2007) 1.56
Characterization of quasispecies of pandemic 2009 influenza A virus (A/H1N1/2009) by de novo sequencing using a next-generation DNA sequencer. PLoS One (2010) 1.56
Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J Virol (2010) 1.44
Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression. J Biol Chem (2008) 1.44
The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate. Vaccine (2005) 1.42
Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2. J Virol (2008) 1.37
Influenza B virus BM2 protein is an oligomeric integral membrane protein expressed at the cell surface. Virology (2003) 1.34
Nectin4 is an epithelial cell receptor for canine distemper virus and involved in neurovirulence. J Virol (2012) 1.34
Neuraminidase inhibitor susceptibility network position statement: antiviral resistance in influenza A/H5N1 viruses. Antivir Ther (2005) 1.33
Measles virus circumvents the host interferon response by different actions of the C and V proteins. J Virol (2008) 1.32
Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010. Influenza Other Respir Viruses (2011) 1.32
Rapid diagnosis of H5N1 avian influenza virus infection by newly developed influenza H5 hemagglutinin gene-specific loop-mediated isothermal amplification method. J Virol Methods (2007) 1.29
Molecular evolutionary analysis of the influenza A(H1N1)pdm, May-September, 2009: temporal and spatial spreading profile of the viruses in Japan. PLoS One (2010) 1.28
Mechanism of up-regulation of human Toll-like receptor 3 secondary to infection of measles virus-attenuated strains. Biochem Biophys Res Commun (2003) 1.28
Translational inhibition and increased interferon induction in cells infected with C protein-deficient measles virus. J Virol (2006) 1.28
The matrix protein of measles virus regulates viral RNA synthesis and assembly by interacting with the nucleocapsid protein. J Virol (2009) 1.24
Antigenic differences between H5N1 human influenza viruses isolated in 1997 and 2003. J Vet Med Sci (2004) 1.21
Oseltamivir-resistant influenza viruses A (H1N1) during 2007-2009 influenza seasons, Japan. Emerg Infect Dis (2010) 1.21
Triggering the measles virus membrane fusion machinery. Proc Natl Acad Sci U S A (2012) 1.20
Multiple amino acid substitutions in hemagglutinin are necessary for wild-type measles virus to acquire the ability to use receptor CD46 efficiently. J Virol (2006) 1.19
Both RIG-I and MDA5 RNA helicases contribute to the induction of alpha/beta interferon in measles virus-infected human cells. J Virol (2010) 1.18
Stringent requirement for the C protein of wild-type measles virus for growth both in vitro and in macaques. J Virol (2005) 1.17
Rapid detection of the severe acute respiratory syndrome (SARS) coronavirus by a loop-mediated isothermal amplification assay. Clin Chem (2004) 1.16
Characterization of the amino acid residues of sendai virus C protein that are critically involved in its interferon antagonism and RNA synthesis down-regulation. J Virol (2004) 1.15
Lethal canine distemper virus outbreak in cynomolgus monkeys in Japan in 2008. J Virol (2012) 1.14
Human H5N2 avian influenza infection in Japan and the factors associated with high H5N2-neutralizing antibody titer. J Epidemiol (2008) 1.14
Altered interaction of the matrix protein with the cytoplasmic tail of hemagglutinin modulates measles virus growth by affecting virus assembly and cell-cell fusion. J Virol (2007) 1.13
Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8. Proc Natl Acad Sci U S A (2005) 1.13
Detection and isolation of highly pathogenic H5N1 avian influenza A viruses from blow flies collected in the vicinity of an infected poultry farm in Kyoto, Japan, 2004. Am J Trop Med Hyg (2006) 1.12
Monitoring and characterization of oseltamivir-resistant pandemic (H1N1) 2009 virus, Japan, 2009-2010. Emerg Infect Dis (2011) 1.12
Ruptured distal anterior inferior cerebellar artery aneurysm following stereotactic irradiation for vestibular schwannoma: case report. Neurol Med Chir (Tokyo) (2009) 1.12
Contributions of matrix and large protein genes of the measles virus edmonston strain to growth in cultured cells as revealed by recombinant viruses. J Virol (2005) 1.12
Efficient rescue of measles virus from cloned cDNA using SLAM-expressing Chinese hamster ovary cells. Virus Res (2005) 1.10
A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice. Int Immunol (2004) 1.10
Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein. J Gen Virol (2005) 1.09
The first autopsy case of pandemic influenza (A/H1N1pdm) virus infection in Japan: detection of a high copy number of the virus in type II alveolar epithelial cells by pathological and virological examination. Jpn J Infect Dis (2010) 1.09
Importance of the anti-interferon capacity of Sendai virus C protein for pathogenicity in mice. J Virol (2007) 1.09
Transmission studies resume for avian flu. Science (2013) 1.07
Detection of 14 alleles derived from the MHC class I A locus in cynomolgus monkeys. Immunogenetics (2004) 1.07
A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir. Virol J (2010) 1.06
The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses. J Virol (2014) 1.05
Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge. Microbes Infect (2007) 1.05
Wild-type measles virus induces large syncytium formation in primary human small airway epithelial cells by a SLAM(CD150)-independent mechanism. Virus Res (2003) 1.05
Diagnostic significance of Aspergillus species isolated from respiratory samples in an adult pneumology ward. Med Mycol (2011) 1.05
Genetic characterization of measles vaccine strains. J Infect Dis (2011) 1.04
Measles virus infection of SLAM (CD150) knockin mice reproduces tropism and immunosuppression in human infection. J Virol (2006) 1.02
Productive infection in the murine central nervous system with avian influenza virus A (H5N1) after intranasal inoculation. Acta Neuropathol (2004) 1.02
Identification of the MHC class I B locus in cynomolgus monkeys. Immunogenetics (2005) 1.01
Epithelial-mesenchymal transition abolishes the susceptibility of polarized epithelial cell lines to measles virus. J Biol Chem (2010) 1.01
Dephosphorylation failure of tyrosine-phosphorylated STAT1 in IFN-stimulated Sendai virus C protein-expressing cells. Virology (2002) 1.01
Structural and functional basis of resistance to neuraminidase inhibitors of influenza B viruses. J Med Chem (2010) 1.01
Mumps virus V protein antagonizes interferon without the complete degradation of STAT1. J Virol (2005) 1.00
Seasonal influenza vaccine policies, recommendations and use in the World Health Organization's Western Pacific Region. Western Pac Surveill Response J (2013) 0.99
Composite Y-graft for syphilitic ostial stenosis in left main coronary artery. Asian Cardiovasc Thorac Ann (2007) 0.98
The amino-terminal half of Sendai virus C protein is not responsible for either counteracting the antiviral action of interferons or down-regulating viral RNA synthesis. J Virol (2002) 0.98
Rescue system for measles virus from cloned cDNA driven by vaccinia virus Lister vaccine strain. J Virol Methods (2006) 0.96
Functional and structural characterization of neutralizing epitopes of measles virus hemagglutinin protein. J Virol (2012) 0.96
Protective immunity afforded by inactivated H5N1 (NIBRG-14) vaccine requires antibodies against both hemagglutinin and neuraminidase in mice. J Infect Dis (2009) 0.96
Development of a real-time PCR assay for detection and quantification of Francisella tularensis. Jpn J Infect Dis (2006) 0.96
Antigenic alteration of influenza B virus associated with loss of a glycosylation site due to host-cell adaptation. J Med Virol (2004) 0.95
Conversion of viable but nonculturable Vibrio cholerae to the culturable state by co-culture with eukaryotic cells. Microbiol Immunol (2010) 0.95
Multilocus sequence typing of Cryptococcus neoformans in non-HIV associated cryptococcosis in Nagasaki, Japan. Med Mycol (2012) 0.95
One-step real-time reverse transcription-PCR assays for detecting and subtyping pandemic influenza A/H1N1 2009, seasonal influenza A/H1N1, and seasonal influenza A/H3N2 viruses. J Virol Methods (2010) 0.95
Comparison of whole genome amplification methods for detecting pathogenic bacterial genomic DNA using microarray. Jpn J Infect Dis (2007) 0.94
Anti-influenza activity of phenethylphenylphthalimide analogs derived from thalidomide. Bioorg Med Chem (2010) 0.94
Ebolavirus VP35 interacts with the cytoplasmic dynein light chain 8. J Virol (2009) 0.93
Isolation of oseltamivir-resistant influenza A/H1N1 virus of different origins in Yokohama City, Japan, during the 2007-2008 influenza season. Jpn J Infect Dis (2009) 0.93
Genotyping and phylogenetic analysis of the major genes in respiratory syncytial virus isolated from infants with bronchiolitis. Jpn J Infect Dis (2010) 0.92
Genetic characterization of measles viruses isolated in Turkey during 2000 and 2001. Virol J (2005) 0.91
A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging. Vaccine (2011) 0.91